Director/PDMR Shareholding

Drax

03/03/2026 15:22

RNS Number : 1808V

Drax Group PLC

03 March 2026

 

3 March 2026

 

Drax Group plc 

("Drax" or "the Company")

 

Symbol: DRX

 

Notification of Transactions of Directors,

Persons Discharging Managerial Responsibility or Connected Persons

 

Sale of shares

Anna Sheffield, a Person Closely Associated with Paul Sheffield, Chief Commercial Officer and a PDMR, has notified the Company that on 3 March 2026 she sold in aggregate 3,072 ordinary shares in the Company for a weighted average share price of 855.519 pence per share.

 

Following the transaction, Paul Sheffield's total shareholding in the Company, including those shares held by spouse, is 83,594 shares.

 

The notification is in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

 

 

Details of PDMR / person closely associated with them ("PCA")
Name
Anna Sheffield
Reason for the notification
Position / status
PCA of Chief Commercial Officer
Initial notification / amendment
Initial Notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name
Drax Group plc
LEI
549300YPSNTXR4ZHSR98
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument
Identification code
Ordinary shares of 11 16/29 pence
GB00B1VNSX38
Nature of the transaction
Sale of ordinary shares
Price(s) and volume(s)
Price(s)
Volume(s)
855.519 pence per share
3,072
Date of the transaction
3 March 2026
Place of the transaction
London Stock Exchange

 

 

--ENDS--

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHJJMATMTTMBBF